Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Down 18.5% in November

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) saw a large decline in short interest in November. As of November 30th, there was short interest totalling 37,500 shares, a decline of 18.5% from the November 15th total of 46,000 shares. Based on an average daily volume of 126,300 shares, the days-to-cover ratio is presently 0.3 days.

Tevogen Bio Price Performance

TVGNW stock remained flat at $0.04 on Friday. The company had a trading volume of 45,865 shares, compared to its average volume of 66,704. The company has a fifty day moving average of $0.06 and a two-hundred day moving average of $0.03. Tevogen Bio has a 52-week low of $0.01 and a 52-week high of $0.28.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.